Back to Search Start Over

A case of pelvic EWSR1-PATZ1 fusion sarcoma treated with carbon ion radiotherapy.

Authors :
Yagi T
Suzuki O
Matsuoka H
Shinyashiki K
Wakamatsu T
Tamiya H
Suzuki R
Kakunaga S
Takenaka S
Hashii Y
Yoshida KI
Nakanishi K
Source :
Radiology case reports [Radiol Case Rep] 2024 Apr 16; Vol. 19 (7), pp. 2674-2678. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).
Publication Year :
2024

Abstract

EWSR1-PATZ1 fusion sarcoma is a type of round-cell sarcoma with EWSR1-non-EST fusion that was newly categorized in the 2020 World Health Organization classification of soft tissue and bone tumors. In general, local disease is managed via surgical resection; however, at present, there is no standard therapy for locally advanced or metastatic disease. Here, we report our experience with a middle-aged male patient with pelvic EWSR1-PATZ1 fusion sarcoma who was treated with carbon ion radiotherapy and maintained stable disease for 13 months. The patient's clinical course suggests that carbon ion radiotherapy may be effective in patients with locally advanced EWSR1-PATZ1 fusion sarcoma.<br /> (© 2024 The Authors. Published by Elsevier Inc. on behalf of University of Washington.)

Details

Language :
English
ISSN :
1930-0433
Volume :
19
Issue :
7
Database :
MEDLINE
Journal :
Radiology case reports
Publication Type :
Report
Accession number :
38645952
Full Text :
https://doi.org/10.1016/j.radcr.2024.03.070